The NASH Drug Pipeline: Progress, Challenges, and Market Insights
Nonalcoholic steatohepatitis (NASH) is a progressive liver disease that has emerged as a significant global health concern. With its prevalence steadily rising, the urgent need for effective treatments has driven major investments in drug development. While there are currently no  NASH therapeutics, numerous candidates are advancing through clinical trials. Researchers and pharmaceutical...
Like
1
0 Comments 0 Shares 2K Views 0 Reviews